Auro Peptides

Auro Peptides is a specialized subsidiary of Aurobindo Pharma Limited, dedicated to the development and commercial-scale manufacturing of peptide Active Pharmaceutical Ingredients (APIs). Based in Hyderabad, India, the company operates a state-of-the-art facility that is USFDA approved and equipped for solid-phase, liquid-phase, and hybrid peptide synthesis. Their extensive portfolio includes high-demand generic peptides such as Liraglutide, Semaglutide, and Teriparatide, targeting metabolic and endocrine disorders. In addition to its own product line, Auro Peptides provides comprehensive Contract Development and Manufacturing Organization (CDMO) services to global pharmaceutical partners. The company leverages its parent's robust regulatory and distribution infrastructure to supply high-purity peptide APIs to international markets.